CRISPR Off-Target Effects Vary by Cell Type and Organ, Study Finds

Companies: AstraZeneca / Integrated DNA Technologies · Finding: CRISPR Off-Targets Vary by Cell and Organ · Publication: Nature Communications · Date: August 26, 2026 Summary An AstraZeneca- and Integrated DNA Technologies-led Nature Communications study found that CRISPR-Cas9 off-target mutations and balanced translocations can differ across…

🔒

Continue reading this signal

Create a free InSilens account to unlock full articles, analysis, and deal context.

Create Free Account
Share this article :

Leave a Reply

Your email address will not be published. Required fields are marked *